Too Old to Operate7 天
Olaparib Shows Long-Term Benefit in High-Risk BRCA1/2-Mutated Breast Cancer
Olaparib improved invasive disease-free survival, distant disease-free survival, and overall survival in high-risk ...
The Himalayan Times14 天
BRCA1 and BRCA2 tests possible in country
For the first time in Nepal, genetic testing, also known as "Gene Sequencing," related to breast cancer (BRCA1 and BRCA2) has ...